FDA Proposes Nicotine Cap at 0.7 mg/g in Cigarettes, Could Help 13 Million Quit
Jan 16, 2025, 04:49 PM
The U.S. Food and Drug Administration (FDA) has proposed a sweeping rule to reduce the addictiveness of cigarettes by capping the nicotine content at 0.7 milligrams per gram of tobacco. This proposal, released on Wednesday, aims to encourage nearly 12% of Americans who still use combustible tobacco products to switch to less harmful alternatives or quit smoking altogether. The rule, which would apply to cigarettes, roll-your-own tobacco, cigars, and pipe tobacco, is expected to take years to go into effect if finalized. The FDA estimates that if implemented, the nicotine reduction could help nearly 13 million additional people quit smoking within one year. The proposal comes as the Biden administration's last major effort to regulate tobacco, following a delay in finalizing a ban on menthol-flavored cigarettes. The incoming Trump administration will need to decide whether to finalize this measure, which was first considered during Trump's initial term.
View original story
No Change • 25%
Increase • 25%
Decrease • 25%
Unclear • 25%
Strongly Support • 25%
Support • 25%
Oppose • 25%
Strongly Oppose • 25%
Legal challenge • 25%
Compliance without challenge • 25%
Other response • 25%
Lobbying against the rule • 25%
Product reformulation • 25%
Legal challenge • 25%
Other • 25%
Compliance • 25%
Compliance without legal challenge • 25%
Non-compliance without legal challenge • 25%
Non-compliance with legal challenge • 25%
Compliance with legal challenge • 25%
Lobbying for amendments • 25%
No significant reaction • 25%
Compliance without challenge • 25%
Legal challenge • 25%
Non-compliance without legal action • 25%
Compliance without legal action • 25%
Compliance with legal action • 25%
Non-compliance and legal action • 25%
No Change • 25%
Increase • 25%
Decrease • 25%
Data Unavailable • 25%
Yes • 50%
No • 50%
Proposal blocked by administration • 25%
Proposal finalized and implemented • 25%
Proposal finalized but not implemented • 25%
Proposal withdrawn by FDA • 25%
Decrease by less than 5% • 25%
No significant change • 25%
Decrease by more than 10% • 25%
Decrease by 5-10% • 25%